首页>
外国专利>
USE OF GLATIRAMER ACETATE AND MITOXANTRONE IN THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT OF MULTIPLE SCLEROSIS
USE OF GLATIRAMER ACETATE AND MITOXANTRONE IN THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT OF MULTIPLE SCLEROSIS
展开▼
机译:醋酸格拉默和米托蒽醌在治疗多发性硬化症的药物生产中的使用
展开▼
页面导航
摘要
著录项
相似文献
摘要
The subject invention provides a method of treating a subject afflicted with a form of multiple sclerosis comprising periodically administering to the subject an amount of glatiramer acetate and an amount of mitoxantrone, wherein the amounts when taken together are effective to alleviate a symptom of the form of multiple sclerosis in the subject so as to thereby treat the subject. The subject invention also provides a package comprising glatiramer acetate, mitoxantrone and instructions for use of the together to alleviate a symptom of a form of multiple sclerosis in a subject. Additionally, the subject invention provides a pharmaceutical composition comprising an amount of glatiramer acetate and an amount of mitoxantrone, wherein the amounts when taken together are effective to alleviate a symptom of a form of multiple sclerosis in a subject. The subject invention further provides a pharmaceutical combination comprising separate dosage forms of an amount of glatiramer acetate and an amount of mitoxantrone, which combination is useful to alleviate a symptom of a form of multiple sclerosis in a subject.
展开▼